Jeff Slezak to Time Factors
This is a "connection" page, showing publications Jeff Slezak has written about Time Factors.
Connection Strength
0.428
-
Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment. Cancer Med. 2020 11; 9(22):8530-8539.
Score: 0.144
-
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021 10 16; 398(10309):1407-1416.
Score: 0.039
-
Follow-up of Abnormal Estimated GFR Results Within a Large Integrated Health Care Delivery System: A Mixed-Methods Study. Am J Kidney Dis. 2019 11; 74(5):589-600.
Score: 0.033
-
Effects of physical activity and sedentary time on the risk of heart failure. Circ Heart Fail. 2014 Jan; 7(1):21-7.
Score: 0.023
-
Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med. 2012 Dec; 166(12):1140-8.
Score: 0.021
-
The Kaiser Permanente experience with ultrasound-guided percutaneous endovascular abdominal aortic aneurysm repair. Ann Vasc Surg. 2012 Oct; 26(7):906-12.
Score: 0.020
-
Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate. Am J Transplant. 2007 Apr; 7(4):880-7.
Score: 0.014
-
Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy. Mayo Clin Proc. 2007 Apr; 82(4):422-7.
Score: 0.014
-
Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance. J Urol. 2006 Aug; 176(2):559-63.
Score: 0.014
-
Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001. Cancer. 2006 Jun 15; 106(12):2630-5.
Score: 0.013
-
Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. J Urol. 2006 Feb; 175(2):547-51.
Score: 0.013
-
Simple graphic method for estimation of prostate-specific antigen doubling time. Urology. 2006 Feb; 67(2):408-9.
Score: 0.013
-
Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy. J Urol. 2004 Dec; 172(6 Pt 1):2244-8.
Score: 0.012
-
Long-term study of the ultrastructural changes of myocardium in patients undergoing cardiac surgery, with more than 10 years follow-up. Int J Cardiol. 1983 Sep; 4(2):153-68.
Score: 0.011
-
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology. 2001 Jun; 57(6):1033-7.
Score: 0.009
-
PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc. 2001 Jun; 76(6):576-81.
Score: 0.009
-
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol. 2000 Jul; 164(1):101-5.
Score: 0.009
-
Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer. 1999 Nov 01; 86(9):1775-82.
Score: 0.008
-
Predictors of early- and late-onset supraventricular tachyarrhythmias after Fontan operation. Circulation. 1998 Sep 15; 98(11):1099-107.
Score: 0.008